We're increasing our Eli Lilly price target after another beat-and-raise quarter

CNBC Published Updated Stocks
Sign in to save

Expected market reaction

Neutral Confidence 50% How confidence is read Horizon: Short term Impact: Low

Evidence trail

Evidence
Source CNBC
Claim We're increasing our Eli Lilly price target after another beat-and-raise quarter
AI inference Neutral · 50%
Generated 2026-08-05 19:28

AI provenance

Analysed by Rule-Based Analysis not AI Methodology v1.0 Generated
Technical identifiers
Provider tag
free-analysis-rule-based-analysis
Analysis version
free-analysis-rule-based-analysis
Article id
115288

Original source

The strength of its GLP-1 business suggests the stock still has more room to run.

Read the full article on CNBC

Original article published by CNBC on August 5, 2026. Analysis and insights provided by AnalystMarkets AI.

Related coverage

This model on similar stories

Rule-Based Analysis · 36.5% correct across 997 scored calls on equities See the full record